World Trade Center Health Program; Petition 006-Primary Biliary Cirrhosis; Finding of Insufficient Evidence, 75528-75529 [2014-29647]

Download as PDF mstockstill on DSK4VPTVN1PROD with PROPOSALS 75528 Federal Register / Vol. 79, No. 243 / Thursday, December 18, 2014 / Proposed Rules submitted regulations revise Indiana’s ambient air quality standards for ozone and particulate matter to be consistent with EPA’s 2008 ozone and 2012 fine particulate matter National Ambient Air Quality Standards. EPA is therefore approving these SIP revisions in accordance with the requirements of the Clean Air Act. In the Final Rules section of this Federal Register, EPA is approving the State’s SIP submittal as a direct final rule without prior proposal because the Agency views this as a noncontroversial submittal and anticipates no adverse comments. A detailed rationale for the approval is set forth in the direct final rule. If no adverse comments are received in response to this action, no further activity is contemplated. If EPA receives adverse comments, the direct final rule will be withdrawn and all public comments received will be addressed in a subsequent final rule based on this proposed rule. EPA will not institute a second comment period. Any parties interested in commenting on this action should do so at this time. DATES: Comments must be received on or before January 20, 2015. ADDRESSES: Submit your comments, identified by Docket ID No. EPA–R05– OAR–2014–0661, by one of the following methods: 1. www.regulations.gov: Follow the on-line instructions for submitting comments. 2. Email: aburano.douglas@epa.gov. 3. Fax: (312) 408–2279. 4. Mail: Douglas Aburano, Chief, Attainment Planning and Maintenance Section, Air Programs Branch (AR–18J), U.S. Environmental Protection Agency, 77 West Jackson Boulevard, Chicago, Illinois 60604. 5. Hand Delivery: Douglas Aburano, Chief, Attainment Planning and Maintenance Section, Air Programs Branch (AR–18J), U.S. Environmental Protection Agency, 77 West Jackson Boulevard, Chicago, Illinois 60604. Such deliveries are only accepted during the Regional Office normal hours of operation, and special arrangements should be made for deliveries of boxed information. The Regional Office official hours of business are Monday through Friday, 8:30 a.m. to 4:30 p.m., excluding Federal holidays. Please see the direct final rule which is located in the Rules section of this Federal Register for detailed instructions on how to submit comments. FOR FURTHER INFORMATION CONTACT: Eric Svingen, Environmental Engineer, Attainment Planning and Maintenance Section, Air Programs Branch (AR–18J), VerDate Sep<11>2014 17:58 Dec 17, 2014 Jkt 235001 Environmental Protection Agency, Region 5, 77 West Jackson Boulevard, Chicago, Illinois 60604, (312) 353–4489, svingen.eric@epa.gov. SUPPLEMENTARY INFORMATION: In the Final Rules section of this Federal Register, EPA is approving the State’s SIP submittal as a direct final rule without prior proposal because the Agency views this as a noncontroversial submittal and anticipates no adverse comments. A detailed rationale for the approval is set forth in the direct final rule. If no adverse comments are received in response to this rule, no further activity is contemplated. If EPA receives adverse comments, the direct final rule will be withdrawn and all public comments received will be addressed in a subsequent final rule based on this proposed rule. EPA will not institute a second comment period. Any parties interested in commenting on this action should do so at this time. Please note that if EPA receives adverse comment on an amendment, paragraph, or section of this rule and if that provision may be severed from the remainder of the rule, EPA may adopt as final those provisions of the rule that are not the subject of an adverse comment. For additional information, see the direct final rule which is located in the Rules section of this Federal Register. Dated: December 5, 2014. Susan Hedman, Regional Administrator, Region 5. [FR Doc. 2014–29587 Filed 12–17–14; 8:45 am] BILLING CODE 6560–50–P DEPARTMENT OF HEALTH AND HUMAN SERVICES 42 CFR Part 88 World Trade Center Health Program; Petition 006—Primary Biliary Cirrhosis; Finding of Insufficient Evidence Centers for Disease Control and Prevention, HHS. ACTION: Denial of petition for addition of a health condition. AGENCY: On October 20, 2014, the Administrator of the World Trade Center (WTC) Health Program received a petition to add primary biliary cirrhosis (Petition 006) to the List of WTC-Related Health Conditions (List). The Administrator has not found sufficient scientific evidence to conduct an analysis of whether to add primary biliary cirrhosis to the List. Accordingly, the Administrator finds that insufficient evidence exists to request a SUMMARY: PO 00000 Frm 00074 Fmt 4702 Sfmt 4702 recommendation of the WTC Health Program Scientific/Technical Advisory Committee (STAC), to publish a proposed rule, or to publish a determination not to publish a proposed rule. DATES: The Administrator of the WTC Health Program is denying this petition for the addition of a health condition as of December 18, 2014. FOR FURTHER INFORMATION CONTACT: Rachel Weiss, Program Analyst, 1090 Tusculum Ave., MS: C–46, Cincinnati, OH 45226; telephone (855)818–1629 (this is a toll-free number); email NIOSHregs@cdc.gov. SUPPLEMENTARY INFORMATION: A. WTC Health Program Statutory Authority Title I of the James Zadroga 9/11 Health and Compensation Act of 2010 (Pub. L. 111–347), amended the Public Health Service Act (PHS Act) to add Title XXXIII 1 establishing the WTC Health Program within the Department of Health and Human Services (HHS). The WTC Health Program provides medical monitoring and treatment benefits to eligible firefighters and related personnel, law enforcement officers, and rescue, recovery, and cleanup workers who responded to the September 11, 2001, terrorist attacks in New York City, at the Pentagon, and in Shanksville, Pennsylvania (responders), and to eligible persons who were present in the dust or dust cloud on September 11, 2001 or who worked, resided, or attended school, childcare, or adult daycare in the New York City disaster area (survivors). All references to the Administrator of the WTC Health Program (Administrator) in this notice mean the Director of the National Institute for Occupational Safety and Health (NIOSH) or his or her designee. Pursuant to section 3312(a)(6)(B) of the PHS Act, interested parties may petition the Administrator to add a health condition to the List in 42 CFR 88.1. Within 60 calendar days after receipt of a petition to add a condition to the List, the Administrator must take one of the following four actions described in section 3312(a)(6)(B) and 42 CFR 88.17: (i) Request a recommendation of the STAC; (ii) publish a proposed rule in the Federal Register to add such health condition; (iii) publish in the Federal Register the Administrator’s determination not to 1 Title XXXIII of the PHS Act is codified at 42 U.S.C. 300mm to 300mm–61. Those portions of the Zadroga Act found in Titles II and III of Public Law 111–347 do not pertain to the WTC Health Program and are codified elsewhere. E:\FR\FM\18DEP1.SGM 18DEP1 Federal Register / Vol. 79, No. 243 / Thursday, December 18, 2014 / Proposed Rules publish such a proposed rule and the basis for such determination; or (iv) publish in the Federal Register a determination that insufficient evidence exists to take action under (i) through (iii) above. B. Petition 006 On October 20, 2014, the Administrator received a petition to add primary biliary cirrhosis to the List (Petition 006).2 The petition was submitted by a Salvation Army responder who worked at Ground Zero in the aftermath of the September 11, 2001, terrorist attacks. The petitioner stated that she had been diagnosed with primary biliary cirrhosis and shared letters from her personal physicians confirming the diagnosis. The petition offered as evidence a number of articles identifying potential associations between primary biliary cirrhosis and other autoimmune diseases to various environmental exposures, including polycyclic aromatic hydrocarbons, xenobiotics, asbestos, and silicon.3 mstockstill on DSK4VPTVN1PROD with PROPOSALS C. Administrator’s Determination on Petition 006 The Administrator has established a methodology for evaluating whether to add non-cancer health conditions to the List of WTC-Related Health Conditions.4 First, the Administrator determines whether published, peer-reviewed studies about the health condition among 9/11-exposed populations are available to assess evidence for a causal relationship and provide a basis for a decision on whether to add the condition to the List. If the studies provide sufficient evidence for analysis, 2 See Petition 006. WTC Health Program: Petitions Received. https://www.cdc.gov/wtc/received.html. 3 Smyk D, Mytilinaiou MG, Rigopoulou EI, Bogdanos DP [2010]. PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York. Disease Markers 29:337–344; Pleil JD, Vette AF, Johnson BA, Rappaport SM [2004]. Air levels of carcinogenic polycyclic aromatic hydrocarbons after the World Trade Center disaster. PNAS 101(32):11685–11688; Dronamraju D, Odin J, Bach N [2010]. Primary biliary cirrhosis: environmental risk factors. Disease Markers 29:323–328; Selmi C, De Santis M, Cavaciocchi F, Gershwin ME [2010]. Infectious agents and xenobiotics in the etiology of primary biliary cirrhosis. Disease Markers 29:287–299; September 11th Worker Protection Task Force. Interim Report. March 4, 2008; Walsh N [2014]. Asbestos revisited: a new autoimmune disease? MedPage Today at https://www.medpagetoday.com/ Rheumatology/GeneralRheumatology/46972; Speck-Hernandez CA and Montoya-Ortiz G [2012]. Silicon, a possible link between environmental exposure and autoimmune diseases: the case of rheumatoid arthritis. Arthritis at https://dx.doi.org/ 10.1155/2012/604187. 4 This methodology, ‘‘Policy and Procedures for Adding Non-Cancer Conditions to the List of WTCRelated Health Conditions,’’ revised October 21, 2014, is available on the WTC Health Program Web site, at https://www.cdc.gov/wtc/policies.html. VerDate Sep<11>2014 17:58 Dec 17, 2014 Jkt 235001 the Administrator proceeds with an assessment of the information. A health condition may be added to the List if published, peer-reviewed direct observational or epidemiologic studies provide substantial support 5 for a causal relationship between 9/11 exposures and the health condition in 9/11-exposed populations. If only epidemiologic studies are available and they provide only modest support 6 for a causal relationship between 9/11 exposures and the health condition, the Administrator may then evaluate studies of associations between the health condition and 9/11 agents.7 If that additional assessment establishes substantial support for a causal relationship between a 9/11 agent or agents and the health condition, the health condition may be added to the List. In accordance with section 3312(a)(6)(B) of the PHS Act and 42 CFR 88.17, described above, the Administrator has reviewed the evidence presented in Petition 006. None of the articles presented with the petition provide sufficient evidence of a causal relationship between primary biliary cirrhosis and 9/11 exposures to establish a basis for a decision on whether to add primary biliary cirrhosis to the List. Although some of the articles identify potential associations between specific 9/11 agents and primary biliary cirrhosis or autoimmune disease in general, none of the articles are peerreviewed direct observational or epidemiologic studies of 9/11 populations, as required by the methodology described above. In addition to reviewing the evidence provided in Petition 006, the Administrator also conducted a search of the existing scientific/medical literature for evidence that could establish a causal relationship between 9/11 exposures and primary biliary cirrhosis. He did not find any peerreviewed, published direct observational or epidemiologic studies 5 The substantial evidence standard is met when the Program assesses all of the available, relevant information and determines with high confidence that the evidence supports its findings regarding a causal association between the 9/11 exposure(s) and the health condition. 6 The modest evidence standard is met when the Program assesses all of the available, relevant information and determines with moderate confidence that the evidence supports its findings regarding a causal association between the 9/11 exposure(s) and the health condition. 7 9/11 agents are chemical, physical, biological, or other agents or hazards reported in a published, peer-reviewed exposure assessment study of responders or survivors who were present in either the New York City disaster area, the Pentagon site, or in Shanksville, Pennsylvania site as defined in 42 CFR part 88. PO 00000 Frm 00075 Fmt 4702 Sfmt 9990 75529 of 9/11-exposed populations which would support such a relationship. Because neither the evidence submitted by the Petitioner nor a search of published scientific/medical literature provided information regarding the occurrence of primary biliary cirrhosis among 9/11-exposed populations, the Administrator has determined that requesting a recommendation from the STAC (pursuant to PHS Act, section 3312(a)(6)(B)(i) and 42 CFR 88.17(a)(2)(i)) is unwarranted. In prior actions, the Administrator requested a recommendation from the STAC when he determined that it would assist his evaluation; such as when, for example, the Administrator is in need of an interpretation of conflicting or inconclusive published scientific evidence. Similarly, the Administrator has determined that insufficient evidence exists to take further action, including either proposing the addition of primary biliary cirrhosis to the List (pursuant to PHS Act, section 3312(a)(6)(B)(ii) and 42 CFR 88.17(a)(2)(ii)) or publishing a determination not to publish a proposed rule in the Federal Register (pursuant to PHS Act, section 3312(a)(6)(B)(iii) and 42 CFR 88.17(a)(2)(iii)). In order to publish such a proposed addition or a determination not to propose a rule, the Administrator would first need to find that enough scientific evidence is available to analyze whether 9/11 exposures are associated with the health condition. Since the Administrator is unable to identify sufficient evidence to conduct an analysis of whether to add the health condition, the Administrator (pursuant to PHS Act, section 3312(a)(6)(B)(iv) and 42 CFR 88.17(a)(2)(iv)) is publishing a determination that he cannot take any of the other statutory and regulatory actions. For the reasons discussed above, the request made in Petition 006 to add primary biliary cirrhosis to the List of WTC-Related Health Conditions is denied. Dated: December 10, 2014. John Howard, Administrator, World Trade Center Health Program and Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Department of Health and Human Services. [FR Doc. 2014–29647 Filed 12–17–14; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\18DEP1.SGM 18DEP1

Agencies

[Federal Register Volume 79, Number 243 (Thursday, December 18, 2014)]
[Proposed Rules]
[Pages 75528-75529]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-29647]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

42 CFR Part 88


World Trade Center Health Program; Petition 006--Primary Biliary 
Cirrhosis; Finding of Insufficient Evidence

AGENCY: Centers for Disease Control and Prevention, HHS.

ACTION: Denial of petition for addition of a health condition.

-----------------------------------------------------------------------

SUMMARY: On October 20, 2014, the Administrator of the World Trade 
Center (WTC) Health Program received a petition to add primary biliary 
cirrhosis (Petition 006) to the List of WTC-Related Health Conditions 
(List). The Administrator has not found sufficient scientific evidence 
to conduct an analysis of whether to add primary biliary cirrhosis to 
the List. Accordingly, the Administrator finds that insufficient 
evidence exists to request a recommendation of the WTC Health Program 
Scientific/Technical Advisory Committee (STAC), to publish a proposed 
rule, or to publish a determination not to publish a proposed rule.

DATES: The Administrator of the WTC Health Program is denying this 
petition for the addition of a health condition as of December 18, 
2014.

FOR FURTHER INFORMATION CONTACT: Rachel Weiss, Program Analyst, 1090 
Tusculum Ave., MS: C-46, Cincinnati, OH 45226; telephone (855)818-1629 
(this is a toll-free number); email NIOSHregs@cdc.gov.

SUPPLEMENTARY INFORMATION:

A. WTC Health Program Statutory Authority

    Title I of the James Zadroga 9/11 Health and Compensation Act of 
2010 (Pub. L. 111-347), amended the Public Health Service Act (PHS Act) 
to add Title XXXIII \1\ establishing the WTC Health Program within the 
Department of Health and Human Services (HHS). The WTC Health Program 
provides medical monitoring and treatment benefits to eligible 
firefighters and related personnel, law enforcement officers, and 
rescue, recovery, and cleanup workers who responded to the September 
11, 2001, terrorist attacks in New York City, at the Pentagon, and in 
Shanksville, Pennsylvania (responders), and to eligible persons who 
were present in the dust or dust cloud on September 11, 2001 or who 
worked, resided, or attended school, childcare, or adult daycare in the 
New York City disaster area (survivors).
---------------------------------------------------------------------------

    \1\ Title XXXIII of the PHS Act is codified at 42 U.S.C. 300mm 
to 300mm-61. Those portions of the Zadroga Act found in Titles II 
and III of Public Law 111-347 do not pertain to the WTC Health 
Program and are codified elsewhere.
---------------------------------------------------------------------------

    All references to the Administrator of the WTC Health Program 
(Administrator) in this notice mean the Director of the National 
Institute for Occupational Safety and Health (NIOSH) or his or her 
designee.
    Pursuant to section 3312(a)(6)(B) of the PHS Act, interested 
parties may petition the Administrator to add a health condition to the 
List in 42 CFR 88.1. Within 60 calendar days after receipt of a 
petition to add a condition to the List, the Administrator must take 
one of the following four actions described in section 3312(a)(6)(B) 
and 42 CFR 88.17: (i) Request a recommendation of the STAC; (ii) 
publish a proposed rule in the Federal Register to add such health 
condition; (iii) publish in the Federal Register the Administrator's 
determination not to

[[Page 75529]]

publish such a proposed rule and the basis for such determination; or 
(iv) publish in the Federal Register a determination that insufficient 
evidence exists to take action under (i) through (iii) above.

B. Petition 006

    On October 20, 2014, the Administrator received a petition to add 
primary biliary cirrhosis to the List (Petition 006).\2\ The petition 
was submitted by a Salvation Army responder who worked at Ground Zero 
in the aftermath of the September 11, 2001, terrorist attacks. The 
petitioner stated that she had been diagnosed with primary biliary 
cirrhosis and shared letters from her personal physicians confirming 
the diagnosis. The petition offered as evidence a number of articles 
identifying potential associations between primary biliary cirrhosis 
and other autoimmune diseases to various environmental exposures, 
including polycyclic aromatic hydrocarbons, xenobiotics, asbestos, and 
silicon.\3\
---------------------------------------------------------------------------

    \2\ See Petition 006. WTC Health Program: Petitions Received. 
https://www.cdc.gov/wtc/received.html.
    \3\ Smyk D, Mytilinaiou MG, Rigopoulou EI, Bogdanos DP [2010]. 
PBC triggers in water reservoirs, coal mining areas and waste 
disposal sites: from Newcastle to New York. Disease Markers 29:337-
344; Pleil JD, Vette AF, Johnson BA, Rappaport SM [2004]. Air levels 
of carcinogenic polycyclic aromatic hydrocarbons after the World 
Trade Center disaster. PNAS 101(32):11685-11688; Dronamraju D, Odin 
J, Bach N [2010]. Primary biliary cirrhosis: environmental risk 
factors. Disease Markers 29:323-328; Selmi C, De Santis M, 
Cavaciocchi F, Gershwin ME [2010]. Infectious agents and xenobiotics 
in the etiology of primary biliary cirrhosis. Disease Markers 
29:287-299; September 11th Worker Protection Task Force. Interim 
Report. March 4, 2008; Walsh N [2014]. Asbestos revisited: a new 
autoimmune disease? MedPage Today at https://www.medpagetoday.com/Rheumatology/GeneralRheumatology/46972; Speck-Hernandez CA and 
Montoya-Ortiz G [2012]. Silicon, a possible link between 
environmental exposure and autoimmune diseases: the case of 
rheumatoid arthritis. Arthritis at https://dx.doi.org/10.1155/2012/604187.
---------------------------------------------------------------------------

C. Administrator's Determination on Petition 006

    The Administrator has established a methodology for evaluating 
whether to add non-cancer health conditions to the List of WTC-Related 
Health Conditions.\4\ First, the Administrator determines whether 
published, peer-reviewed studies about the health condition among 9/11-
exposed populations are available to assess evidence for a causal 
relationship and provide a basis for a decision on whether to add the 
condition to the List. If the studies provide sufficient evidence for 
analysis, the Administrator proceeds with an assessment of the 
information. A health condition may be added to the List if published, 
peer-reviewed direct observational or epidemiologic studies provide 
substantial support \5\ for a causal relationship between 9/11 
exposures and the health condition in 9/11-exposed populations. If only 
epidemiologic studies are available and they provide only modest 
support \6\ for a causal relationship between 9/11 exposures and the 
health condition, the Administrator may then evaluate studies of 
associations between the health condition and 9/11 agents.\7\ If that 
additional assessment establishes substantial support for a causal 
relationship between a 9/11 agent or agents and the health condition, 
the health condition may be added to the List.
---------------------------------------------------------------------------

    \4\ This methodology, ``Policy and Procedures for Adding Non-
Cancer Conditions to the List of WTC-Related Health Conditions,'' 
revised October 21, 2014, is available on the WTC Health Program Web 
site, at https://www.cdc.gov/wtc/policies.html.
    \5\ The substantial evidence standard is met when the Program 
assesses all of the available, relevant information and determines 
with high confidence that the evidence supports its findings 
regarding a causal association between the 9/11 exposure(s) and the 
health condition.
    \6\ The modest evidence standard is met when the Program 
assesses all of the available, relevant information and determines 
with moderate confidence that the evidence supports its findings 
regarding a causal association between the 9/11 exposure(s) and the 
health condition.
    \7\ 9/11 agents are chemical, physical, biological, or other 
agents or hazards reported in a published, peer-reviewed exposure 
assessment study of responders or survivors who were present in 
either the New York City disaster area, the Pentagon site, or in 
Shanksville, Pennsylvania site as defined in 42 CFR part 88.
---------------------------------------------------------------------------

    In accordance with section 3312(a)(6)(B) of the PHS Act and 42 CFR 
88.17, described above, the Administrator has reviewed the evidence 
presented in Petition 006. None of the articles presented with the 
petition provide sufficient evidence of a causal relationship between 
primary biliary cirrhosis and 9/11 exposures to establish a basis for a 
decision on whether to add primary biliary cirrhosis to the List. 
Although some of the articles identify potential associations between 
specific 9/11 agents and primary biliary cirrhosis or autoimmune 
disease in general, none of the articles are peer-reviewed direct 
observational or epidemiologic studies of 9/11 populations, as required 
by the methodology described above.
    In addition to reviewing the evidence provided in Petition 006, the 
Administrator also conducted a search of the existing scientific/
medical literature for evidence that could establish a causal 
relationship between 9/11 exposures and primary biliary cirrhosis. He 
did not find any peer-reviewed, published direct observational or 
epidemiologic studies of 9/11-exposed populations which would support 
such a relationship.
    Because neither the evidence submitted by the Petitioner nor a 
search of published scientific/medical literature provided information 
regarding the occurrence of primary biliary cirrhosis among 9/11-
exposed populations, the Administrator has determined that requesting a 
recommendation from the STAC (pursuant to PHS Act, section 
3312(a)(6)(B)(i) and 42 CFR 88.17(a)(2)(i)) is unwarranted. In prior 
actions, the Administrator requested a recommendation from the STAC 
when he determined that it would assist his evaluation; such as when, 
for example, the Administrator is in need of an interpretation of 
conflicting or inconclusive published scientific evidence.
    Similarly, the Administrator has determined that insufficient 
evidence exists to take further action, including either proposing the 
addition of primary biliary cirrhosis to the List (pursuant to PHS Act, 
section 3312(a)(6)(B)(ii) and 42 CFR 88.17(a)(2)(ii)) or publishing a 
determination not to publish a proposed rule in the Federal Register 
(pursuant to PHS Act, section 3312(a)(6)(B)(iii) and 42 CFR 
88.17(a)(2)(iii)). In order to publish such a proposed addition or a 
determination not to propose a rule, the Administrator would first need 
to find that enough scientific evidence is available to analyze whether 
9/11 exposures are associated with the health condition. Since the 
Administrator is unable to identify sufficient evidence to conduct an 
analysis of whether to add the health condition, the Administrator 
(pursuant to PHS Act, section 3312(a)(6)(B)(iv) and 42 CFR 
88.17(a)(2)(iv)) is publishing a determination that he cannot take any 
of the other statutory and regulatory actions.
    For the reasons discussed above, the request made in Petition 006 
to add primary biliary cirrhosis to the List of WTC-Related Health 
Conditions is denied.

    Dated: December 10, 2014.
John Howard,
Administrator, World Trade Center Health Program and Director, National 
Institute for Occupational Safety and Health, Centers for Disease 
Control and Prevention, Department of Health and Human Services.
[FR Doc. 2014-29647 Filed 12-17-14; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.